Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 11, Special Issue 10 (2022)

Therapeutic management of non-infectious repeat breeder buffaloes using GNRH analogue

Author(s):
Md. Zakiuddin, MK Tandle, SM Usturge, NA Patil, D Dilip Kumar, VR Kasaralikar and MD Suranagi
Abstract:
The study was conducted to determine the effect of GnRH (Buserelin Acetate) administration as a therapy for repeat breeding syndrome in 30 buffaloes. White side test was carried out to exclude the possibility of sub-clinical genital infection in these animals. The repeat breeder buffaloes which were found to be negative for White side test were divided randomly into three equal groups (n=10). The Group I buffaloes received GnRH analogue 10μg at the time of insemination, Group II received GnRH analogue 10μg at the time of insemination and another dose of GnRH analogue 10μg on 12th day post insemination. Group III kept as control. The Vaginal Electrical Resistance (VER) values of pregnant (242±6.27) and non-pregnant buffaloes (262.04±7.07) differ significantly (p<0.05). The color of estrual mucus in repeat breeder buffaloes was 62.50% transparent, 37.50% translucent and 00.00% whitish. 16.67%, 45.83% and 37.50% of repeat breeder buffaloes were having thick, viscous and thin consistency of estrual mucus. The mean pH value of estrual mucus was 7.37±0.04. Conception rate in buffaloes is more when cervico-vaginal mucus on the day of estrus is transparent, viscous, with typical fern pattern, spinnbarkeit value more than 10 cm and pH ranges 7-8. Conception rate in repeat breeder buffaloes was 90%, 70% and 10% in Group II, I and III respectively.
Pages: 2061-2065  |  186 Views  54 Downloads
How to cite this article:
Md. Zakiuddin, MK Tandle, SM Usturge, NA Patil, D Dilip Kumar, VR Kasaralikar and MD Suranagi. Therapeutic management of non-infectious repeat breeder buffaloes using GNRH analogue. The Pharma Innovation Journal. 2022; 11(10S): 2061-2065.

Call for book chapter